Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid

Lancet

Volumn 357, Issue 9263, 2001, Pages 1179-

  Gonzales, Ronald D ^a   Schreckenberger, Paul C ^a   Graham, Mary Beth ^a   Kelkar, Swathi ^a   DenBesten, Karen ^b   Quinn, John P ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b Lakeshore Infectious Disease Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DALFOPRISTIN; DOXYCYCLINE; LINEZOLID; QUINUPRISTIN; VANCOMYCIN;

ABSCESS; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; AORTA ANEURYSM; ARTICLE; BACTERIAL INFECTION; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; DRUG EFFICACY; EMPYEMA; ENTEROCOCCUS FAECIUM; FISTULA; GRAFT REJECTION; HUMAN; KIDNEY GRAFT; LIVER ABSCESS; LIVER TRANSPLANTATION; MALE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; TREATMENT FAILURE;

EID: 0035857967     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)04376-2     Document Type: Article

References (5)

1. Development of linezolid-resistant Enterococcus faecium in two compassionate use program patients treated with linezolid
2. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites
3. Oxazolidinone resistance mutations in 23S rRNA of Escheri chia coli reveal the central region of domain V as the primary site of drug action